Risks of Proteinuria Associated with Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis

Open Access

Peer-reviewed

Research Article

Ze-Feng Zhang ,

Contributed equally to this work with: Ze-Feng Zhang, Tao Wang

Affiliation Department of Thoracic Surgery, Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China
⨯
Tao Wang ,

Contributed equally to this work with: Ze-Feng Zhang, Tao Wang

* E-mail: wangtao130928@163.com

Affiliation Department of Thoracic Surgery, Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China
⨯
Li-Hua Liu,

Affiliation Department of Biological therapy, Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China
⨯
Hui-Qin Guo

Affiliation Department of Pathology, Cancer institute and Hospital Chinese Academi of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China
⨯

Reader Comments (0)

Proteinuria
Is the Subject Area "Proteinuria" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Cancer risk factors
Is the Subject Area "Cancer risk factors" applicable to this article?

Thanks for your feedback.
Renal cell carcinoma
Is the Subject Area "Renal cell carcinoma" applicable to this article?

Thanks for your feedback.
Renal cancer
Is the Subject Area "Renal cancer" applicable to this article?

Thanks for your feedback.
Cancer epidemiology
Is the Subject Area "Cancer epidemiology" applicable to this article?

Thanks for your feedback.
Metaanalysis
Is the Subject Area "Metaanalysis" applicable to this article?

Thanks for your feedback.
Non-small cell lung cancer
Is the Subject Area "Non-small cell lung cancer" applicable to this article?

Thanks for your feedback.